Maravai Lifesciences Holdings 

Maravai Lifesciences Holdings 

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$51,442
$65,837
$49,866
$41,630
Gross Profit
20,650
33,701
12,242
5,655
EBITDA
-5,211
12,199
-41,721
-22,463
EBIT
-16,993
-779
-56,454
-38,305
Net Income
-12,416
-3,733
-35,681
-25,556
Net Change In Cash
51,442
65,837
49,866
41,630
Free Cash Flow
3,622
4,228
-24,882
-18,076
Cash
70,091
165,922
216,890
243,574
Basic Shares
147,996
146,426
145,074
144,683

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$185,743
$259,185
$288,945
$883,001
Gross Profit
33,390
108,309
140,202
714,044
EBITDA
-147,111
-156,917
712,409
609,989
EBIT
-207,982
-213,782
663,628
571,886
Net Income
-130,773
-144,846
-119,029
220,205
Net Change In Cash
185,743
259,185
288,945
883,001
Free Cash Flow
-70,722
-22,193
60,671
518,887
Cash
216,890
322,399
574,962
632,138
Basic Shares
145,074
137,906
131,919
131,695

Earnings Calls

QuarterEPS
2026-06-30
-$0.07
2026-03-31
$0.01
2025-12-31
-$0.04
2025-09-30
-$0.08